Navigation Links
Poniard Pharmaceuticals Announces Upcoming Conference Participation
Date:5/1/2008

SOUTH SAN FRANCISCO, Calif., May 1 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that Jerry McMahon, Ph.D., chairman and CEO, will participate in two upcoming conferences in May:

-- The Leerink Swann "Conquering Cancer with Novel Therapeutics"

Roundtable Conference on May 9 at 1:35 p.m. Eastern Time at the Grand

Hyatt New York

-- The CitiGroup Health Care Conference on May 21 at 9:30 a.m. Eastern

Time at the New York Hilton

A live audio webcast of the presentation at CitiGroup will be available for 10 business days on the "Events" page of the "News & Events" section of the Company's website at http://www.poniard.com.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum therapy with an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors, and is being studied in multiple cancer indications, combinations and formulations. Clinical trials of intravenous picoplatin include a Phase 3 trial in small cell lung cancer and Phase 2 trials in metastatic colorectal and hormone-refractory prostate cancers, as well as a Phase 1 clinical trial of oral picoplatin in solid tumors. Picoplatin has not been approved by any regulatory authority for use in humans. For additional information please visit http://www.poniard.com.


'/>"/>
SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
2. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
3. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
5. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
11. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/27/2020)... ... January 27, 2020 , ... Valencell, the ... from strategic investors led by Halma plc , a FTSE 100 global ... Ventures, GII LLC, and WSJ Joshua Fund. A representative from Halma will join ...
(Date:1/24/2020)... (PRWEB) , ... January 24, 2020 , ... ... innovations created by companies in biotechnology, diagnostics, therapeutics, laboratory and clinical services during ... millions of people around the world. And as Slone Partners celebrates ...
(Date:1/23/2020)... , ... January 22, 2020 , ... ... developments in the cosmetic surgery industry at two recent North American investor forums ... at the Canaccord Genuity Medical Technologies & Diagnostics Forum on November 21, 2019 ...
(Date:1/22/2020)... ... January 21, 2020 , ... Microbial Discovery Group LLC (MDG) ... Industrial and Institutional (I&I) Account Manager. Darrell will focus on servicing MDG’s partners ... over 30 years of sales experience working across multiple different market sectors such ...
Breaking Biology Technology:
(Date:1/23/2020)... BOSTON (PRWEB) , ... January ... ... part of a new public-private Manufacturing USA initiative, the Advanced Regenerative Manufacturing ... USA Institute. ARMI brings together a consortium of over 100 partner organizations ...
(Date:1/22/2020)... HOUSTON (PRWEB) , ... January ... ... specializes in integrating cold chain operations, developing transport validation strategies, supporting ... recognition by both Inc. 5000 and the Houston Business Journal as a ...
(Date:1/7/2020)... FORT WORTH, Texas (PRWEB) , ... January 07, ... ... of its 2020 prospectus. The Lifecycle prospectus features not just part numbers like ... business, it’s manufacturing facilities, the industries it supports, and that is all linked ...
Breaking Biology News(10 mins):